Literature DB >> 12056291

[Synovial membrane diagnostic assessment in rheumatoid arthritis].

B Ostendorf1, P Dann, J Friemann, T Pauly, M Schneider.   

Abstract

Rheumatoid arthritis (RA) is the most frequent inflammatory rheumatic disease. At the beginning of the disease, where, based on today's knowledge the therapeutic possibilities are largest, the diagnostic methods do not permit a differentiated estimation of the prognosis. Conventional x-rays are mostly normal and serum markers unspecific. So far--in contrast to other diseases--only little information had been drawn from the pathomorphologic substrate "synovialis" itself to assess the prognosis. Reasons therefor were found in difficulties in obtaining synovial tissue besides surgical interventions, particularly in patients with early arthritis. By minimalizing the diagnostic instruments and improvement of the technique, synovial tissue sampling in RA has become minimally invasive and it is even possible to perform on the smallest joints, such as finger joints. Hereby, synovial analysis is open for detecting pathways of inflammation and joint destruction, which might support the advancement of new therapeutic strategies, followed by a better prognosis and outcome of RA.

Entities:  

Mesh:

Year:  2002        PMID: 12056291     DOI: 10.1007/s003930200022

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  3 in total

1.  [Diagnostic imaging in rheumatology].

Authors:  M Schneider
Journal:  Z Rheumatol       Date:  2002-04       Impact factor: 1.372

Review 2.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 3.  Targeting Acquired Hemophilia A with Rheumatoid Arthritis by a Rituximab Shot: A Case Report and Review of the Literature.

Authors:  Imad Ghozlani; Aziza Mounach; Mirieme Ghazi; Anass Kherrab; Radouane Niamane
Journal:  Am J Case Rep       Date:  2018-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.